Richard A. Stanton

1.3k total citations
27 papers, 803 citations indexed

About

Richard A. Stanton is a scholar working on Molecular Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Richard A. Stanton has authored 27 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Medicine, 11 papers in Infectious Diseases and 10 papers in Molecular Biology. Recurrent topics in Richard A. Stanton's work include Antibiotic Resistance in Bacteria (13 papers), HIV/AIDS drug development and treatment (8 papers) and Vibrio bacteria research studies (6 papers). Richard A. Stanton is often cited by papers focused on Antibiotic Resistance in Bacteria (13 papers), HIV/AIDS drug development and treatment (8 papers) and Vibrio bacteria research studies (6 papers). Richard A. Stanton collaborates with scholars based in United States, Australia and Uganda. Richard A. Stanton's co-authors include James H. Nettles, Ritu Aneja, Kim M. Gernert, Raymond F. Schinazi, Bryan D. Cox, Alison Laufer Halpin, Franck Amblard, James J. Kohler, Maryam Ehteshami and Gillian McAllister and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioinformatics and PLoS ONE.

In The Last Decade

Richard A. Stanton

25 papers receiving 793 citations

Peers

Richard A. Stanton
Michael Hornsby United States
Jutta Heim Switzerland
Hie-Joon Kim South Korea
Xuefu You China
W E Kohlbrenner United States
Tomislav Karoli Australia
Richard A. Stanton
Citations per year, relative to Richard A. Stanton Richard A. Stanton (= 1×) peers S.C. Mosimann

Countries citing papers authored by Richard A. Stanton

Since Specialization
Citations

This map shows the geographic impact of Richard A. Stanton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard A. Stanton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard A. Stanton more than expected).

Fields of papers citing papers by Richard A. Stanton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard A. Stanton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard A. Stanton. The network helps show where Richard A. Stanton may publish in the future.

Co-authorship network of co-authors of Richard A. Stanton

This figure shows the co-authorship network connecting the top 25 collaborators of Richard A. Stanton. A scholar is included among the top collaborators of Richard A. Stanton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard A. Stanton. Richard A. Stanton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, Sophie, et al.. (2025). Community-associated New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales: multiple states, from September 2021 through September 2022. Infection Control and Hospital Epidemiology. 46(5). 544–547. 1 indexed citations
2.
Medrzycki, Magdalena, Richard A. Stanton, Danielle A. Rankin, et al.. (2023). 1932. Molecular Epidemiology of NDM-producing Acinetobacter baumannii in the US—October 2013—March 2022. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
3.
Habrun, Caroline, Wendy Wilson, Leslie Kollmann, et al.. (2023). New Delhi metallo-β-lactamase–producing Escherichia coli among dogs at an animal rescue facility—Wisconsin, 2022. SHILAP Revista de lepidopterología. 3(S2). s90–s90.
4.
Cameron, Andrew, Heba H. Mostafa, Samantha Taffner, et al.. (2021). Detection of CTX-M-27 β-Lactamase Genes on Two Distinct Plasmid Types in ST38 Escherichia coli from Three U.S. States. Antimicrobial Agents and Chemotherapy. 65(7). e0082521–e0082521. 12 indexed citations
5.
Ham, D. Cal, Liore Klein, Nychie Dotson, et al.. (2021). Gram-Negative Bacteria Harboring Multiple Carbapenemase Genes, United States, 2012–2019. Emerging infectious diseases. 27(9). 2475–2479. 16 indexed citations
6.
Novosad, Shannon, Jason Lake, Duc B. Nguyen, et al.. (2019). Multicenter Outbreak of Gram-Negative Bloodstream Infections in Hemodialysis Patients. American Journal of Kidney Diseases. 74(5). 610–619. 10 indexed citations
7.
Karlsson, Maria, Richard A. Stanton, Uzma Ansari, et al.. (2019). Identification of a Carbapenemase-Producing Hypervirulent Klebsiella pneumoniae Isolate in the United States. Antimicrobial Agents and Chemotherapy. 63(7). 69 indexed citations
8.
Stanton, Richard A., Gillian McAllister, Maria Karlsson, et al.. (2019). 603. Identification of a Carbapenemase-Producing, Extensively Drug-Resistant Klebsiella pneumoniae Isolate Carrying a blaNDM-1-Bearing, Hypervirulent Plasmid, United States 2017. Open Forum Infectious Diseases. 6(Supplement_2). S282–S283. 1 indexed citations
9.
Ehteshami, Maryam, Longhu Zhou, Jadd R. Shelton, et al.. (2017). Nucleotide Substrate Specificity of Anti-Hepatitis C Virus Nucleoside Analogs for Human Mitochondrial RNA Polymerase. Antimicrobial Agents and Chemotherapy. 61(8). 8 indexed citations
10.
Stanton, Richard A., Xiao Lu, Mervi Detorio, et al.. (2016). Discovery, characterization, and lead optimization of 7-azaindole non-nucleoside HIV-1 reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(16). 4101–4105. 15 indexed citations
11.
Tao, Sijia, Franck Amblard, Richard A. Stanton, et al.. (2015). Design, synthesis and evaluation of novel anti-HCV molecules that deliver intracellularly three highly potent NS5A inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(17). 3711–3715. 2 indexed citations
12.
Stanton, Richard A., James H. Nettles, & Raymond F. Schinazi. (2015). Ligand similarity guided receptor selection enhances docking accuracy and recall for non-nucleoside HIV reverse transcriptase inhibitors. Journal of Molecular Modeling. 21(11). 282–282. 5 indexed citations
13.
Wadford, Debra A., Robert C. Kauffman, Jesse D. Deere, et al.. (2014). Variation of Human Immunodeficiency Virus Type-1 Reverse Transcriptase within the Simian Immunodeficiency Virus Genome of RT-SHIV. PLoS ONE. 9(1). e86997–e86997. 1 indexed citations
14.
Nettles, James H., Richard A. Stanton, Franck Amblard, et al.. (2014). Asymmetric Binding to NS5A by Daclatasvir (BMS-790052) and Analogs Suggests Two Novel Modes of HCV Inhibition. Journal of Medicinal Chemistry. 57(23). 10031–10043. 35 indexed citations
15.
Schinazi, Raymond F., James J. Kohler, James H. Nettles, et al.. (2014). Approaches to hepatitis C treatment and cure using NS5A inhibitors. Infection and Drug Resistance. 41–41. 45 indexed citations
16.
Mishra, Ram Chandra, Prasanthi Karna, Sushma R. Gundala, et al.. (2011). Second generation benzofuranone ring substituted noscapine analogs: Synthesis and biological evaluation. Biochemical Pharmacology. 82(2). 110–121. 51 indexed citations
17.
Stanton, Richard A., Kim M. Gernert, James H. Nettles, & Ritu Aneja. (2011). Drugs that target dynamic microtubules: A new molecular perspective. Medicinal Research Reviews. 31(3). 443–481. 422 indexed citations
18.
Schinazi, Raymond F., Ivana Massud, Mervi Detorio, et al.. (2011). Selection and Characterization of HIV-1 with a Novel S68 Deletion in Reverse Transcriptase. Antimicrobial Agents and Chemotherapy. 55(5). 2054–2060. 7 indexed citations
19.
Stanton, Richard A., Kim M. Gernert, James H. Nettles, & Ritu Aneja. (2011). ChemInform Abstract: Drugs that Target Dynamic Microtubules: A New Molecular Perspective. ChemInform. 42(30). 2 indexed citations
20.
Gerren, Richard A., et al.. (1996). An overview of automated biotechnology screening. 8(5). 287–294. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026